Article metrics

Download PDFPDF
EP936 A feasibility study of gemcitabine and bevacizumab in women with platinum-resistant recurrent ovarian cancer

 

Online download statistics by month:

Online download statistics by month: November 2019 to April 2024

AbstractFullPdf
Nov 20194501
Dec 20191600
Jan 20202600
Feb 20203302
Mar 2020901
Apr 2020701
May 20201701
Jun 20201901
Jul 20203600
Aug 20201400
Sep 20202300
Oct 20206400
Nov 20205000
Dec 20201601
Jan 20211200
Feb 20211700
Mar 20212200
Apr 2021800
May 2021400
Oct 2021900
Nov 20211100
Dec 20211000
Jan 20221900
Feb 20221000
Mar 20221200
Apr 2022800
May 20221800
Jun 20222200
Jul 20222600
Aug 20225601
Sep 20223600
Oct 20223200
Nov 20224400
Dec 20222600
Jan 20231800
Feb 20232200
Mar 20232800
Apr 20234300
May 20233400
Jun 20232700
Jul 20232000
Aug 20233000
Sep 20232400
Oct 20231800
Nov 20232400
Dec 20232400
Jan 2024600
Feb 2024800
Mar 20243200
Apr 20243000
Total116509